lomustine has been researched along with Anemia in 6 studies
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Excerpt | Relevance | Reference |
---|---|---|
"To improve survival of elderly patients with primary central nervous system lymphoma (PCNSL), we conducted a phase II study with high-dose methotrexate (MTX) combined with procarbazine and CCNU." | 2.74 | High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study. ( Deckert, M; Feuerhake, F; Finke, J; Ihorst, G; Illerhaus, G; Marks, R; Müller, F; Ostertag, C, 2009) |
"Thirty-two patients with recurrent Hodgkin's disease have been treated with an oral regimen employing lomustine (CCNU, 100 mg/m2 orally on Day 1); etoposide (VP-16, 100 mg/m2 orally on Days 1-3 and 21-23); and methotrexate (30 mg/m2 orally on Days 1, 8, 21, and 28)." | 1.27 | Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate. ( Coleman, CN; Horning, SJ; Jacobs, C; Lewis, BJ; Rosenberg, SA; Tseng, A, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Illerhaus, G | 1 |
Marks, R | 1 |
Müller, F | 1 |
Ihorst, G | 1 |
Feuerhake, F | 1 |
Deckert, M | 1 |
Ostertag, C | 1 |
Finke, J | 1 |
Heading, KL | 1 |
Brockley, LK | 1 |
Bennett, PF | 1 |
Morabito, F | 1 |
Hohaus, S | 1 |
Mammi, C | 1 |
Marcheselli, L | 1 |
Gentile, M | 1 |
Merli, F | 1 |
Montanini, A | 1 |
Stelitano, C | 1 |
La Sala, A | 1 |
Scalone, R | 1 |
Voso, MT | 1 |
Luminari, S | 1 |
Iannitto, E | 1 |
Gobbi, P | 1 |
Federico, M | 1 |
Gershanovich, ML | 1 |
Akimov, MA | 1 |
Colombi, M | 1 |
Guffanti, A | 1 |
Alietti, A | 1 |
Latargia, ML | 1 |
Vener, C | 1 |
Maiolo, AT | 1 |
Baldini, L | 1 |
Tseng, A | 1 |
Jacobs, C | 1 |
Coleman, CN | 1 |
Horning, SJ | 1 |
Lewis, BJ | 1 |
Rosenberg, SA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Treatment of Patients Over 65 Years With Primary CNS Lymphoma: High-dose Methotrexate Combined With Chemo-immunotherapy Followed by Maintenance Therapy[NCT00989352] | Phase 2 | 56 participants (Anticipated) | Interventional | 2009-09-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 trials available for lomustine and Anemia
Article | Year |
---|---|
High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Comb | 2009 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carbopl | 2012 |
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cau | 2000 |
3 other studies available for lomustine and Anemia
Article | Year |
---|---|
CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
Topics: Anemia; Animals; Antineoplastic Agents, Alkylating; Dog Diseases; Dogs; Female; Gastrointestinal Dis | 2011 |
[Evaluation of the CCNU-COP regimen for primary refractory and recurrent non-Hodgkin's lymphoma].
Topics: Adult; Aged; Anemia; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protoco | 1999 |
Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocol | 1987 |